A monoclonal antibody halted the production of peanut-specific IgE in peanut-allergic mice and in blood samples from people with peanut… Read more »
Dupilumab Led to Asthma Remission for Some About 30 percent of patients taking the biologic drug dupilumab experienced “remission” of… Read more »
Dupilumab Reduced Severe Asthma in Children The biologic drug dupilumab markedly improved lung function while also reducing severe asthma attacks… Read more »
Painful, red eczema patches used to run up and down Benjamin Sun’s arms and legs. This severe atopic dermatitis led… Read more »
A physician and a new biologic drug have been freeing eczema patients of endless itch. Since this article first appeared… Read more »
This is a sidebar to Allergic Living’s feature: Breakthrough Therapy Changing the Lives of Those Living With Eczema. Dupilumab is… Read more »
New York researchers at Mount Sinai are easing the relentless itch of eczema with a new drug. Dubbed a “breakthrough” therapy by the FDA, it treats eczema’s source rather than just its symptoms.